| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 10 | -224K | 100% | $14.11 | -$3.16M |
| Net | -10 | -224K | -100% | -$3.16M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Eric M. Dube | CHIEF EXECUTIVE OFFICER, Director | $6.84M | -$619K | -8.3% | Jan 22, 2025 |
| Peter Heerma | Chief Commercial Officer | $2.01M | -$91K | -4.32% | Jan 22, 2025 |
| William E. Rote | Senior Vice President, R&D | $1.62M | -$139K | -7.93% | Jan 22, 2025 |
| Elizabeth E. Reed | Svp, Gc & Corporate Secretary | $1.5M | -$139K | -8.52% | Jan 22, 2025 |
| Christopher R. Cline | Chief Financial Officer | $1.4M | -$82.9K | -5.6% | Jan 22, 2025 |
| Steve Aselage | Director | $1.32M | May 11, 2022 | ||
| Jeffrey Meckler | Director | $1.14M | -$562K | -33.1% | Sep 30, 2024 |
| Jula Inrig | Chief Medical Officer | $1.12M | -$100K | -8.26% | Jan 3, 2025 |
| Sandra Calvin | Svp, Chief Accounting Officer | $1.02M | -$521K | -33.8% | Jan 22, 2025 |
| Gary A. Lyons | Director | $773K | -$589K | -43.3% | Oct 4, 2024 |
| Roy D. Baynes | Director | $620K | -$320K | -34% | Jan 23, 2025 |
| Noah L. Rosenberg | Chief Medical Officer | $427K | Aug 13, 2021 | ||
| Timothy Coughlin | Director | $330K | May 8, 2024 | ||
| Laura Clague | Chief Financial Officer | $319K | May 10, 2022 | ||
| John A. Orwin | Director | $195K | May 8, 2024 | ||
| Ron Squarer | Director | $195K | May 8, 2024 | ||
| Sandra Poole | Director | $158K | May 8, 2024 | ||
| Suzanne Louise Bruhn | Director | $150K | May 8, 2024 | ||
| Brinkley Ruth Williams | Director | $130K | May 8, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|